-+ 0.00%
-+ 0.00%
-+ 0.00%

Synopsys (SNPS) Stock Looks Overvalued Even With Stronger Cash Flow Outlook

Simply Wall St·11/20/2026 11:09:59
语音播报

Synopsys has had a mixed share price path in recent years, with a gain of 23.4% over 5 years but a softer patch more recently. That leaves investors asking whether the current US$430.91 price is backed up by the cash the business is expected to generate. With the market now refocusing on fundamentals after sharp moves in high profile AI stocks, the key issue for Synopsys is how its cash flows compare with today's valuation.

  • The 23.4% return over 5 years means long term holders are sitting on meaningful gains. Any reassessment of the stock now turns on what those past years of compounding imply for the cash flows still ahead.
  • Fresh earnings news and higher internal targets for revenue and free cash flow suggest the company now sees stronger cash generation, which can influence how comfortably investors view the current price against its expected cash stream.
  • If you'd rather focus on earnings, this one's for you. See what Synopsys's 76.7x P/E says about the price.

The issue now is whether Synopsys's present share price is fully supported by the intrinsic value indicated by its cash flows, as estimated by the Discounted Cash Flow (DCF) approach.

If you are weighing whether Synopsys's cash flows justify its current valuation, it can help to ask the same question across 35 high quality undervalued stocks.

Does Synopsys Look Pricey on Cash Flow?

The Discounted Cash Flow (DCF) approach here looks at the cash Synopsys is expected to generate for shareholders over time. Based on the latest twelve months, the business produced free cash flow of about $2.7b, and the model then carries this forward using a 2 Stage Free Cash Flow to Equity framework that assumes growing cash generation before settling into a steadier phase.

Those projections build to forecast free cash flow reaching several billion dollars a year over the coming decade, yet the DCF output indicates an intrinsic value that is meaningfully below the current $430.91 share price. Recent news that Synopsys posted strong Q3 results and raised full year free cash flow guidance helps explain why investors are comfortable paying a higher price, even where the cash flow model reads as cautious on valuation. Find out what Synopsys could be worth using our Discounted Cash Flow (DCF) estimate.

The Synopsys Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Synopsys pick up where the valuation question leaves off. They spell out which combinations of growth, profitability and earnings paths would need to play out for the stock to look materially above or below today's price, and each one ties its number to a clear view on how Synopsys' growth, margins and risk profile could evolve, giving you something specific to revisit as fresh information comes through.

One of the top narratives on Synopsys: 26% undervalued

This Narrative is the analyst consensus Narrative on Simply Wall St, which compiles analysts' consensus price target and revenue and earnings forecasts, not one person's view.

"The main execution priority is integrating Ansys effectively and scaling agentic AI and customized IP offerings while also managing restructuring costs and legal and index related headwinds..."

Discover why this Narrative puts Synopsys at 26% undervalued.

One more Synopsys check that belongs beside the valuation work

Price and cash flow only tell part of the story for Synopsys, because the broader research flags specific concerns that investors often want to weigh before feeling comfortable with any conclusion. Take a closer look at 2 warning signs before settling on a valuation.